Select for export Psilocybin: Psychotherapy or drug? No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675757 PubMed 27909167 Copy citation Copy BibTeX Unknown journal 2016-11-30 Goodwin GM. Europe PMC Published psilocybin General Other More
Select for export Psilocybin in end of life care: Implications for further research. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675758 PubMed 27909168 Copy citation Copy BibTeX Unknown journal 2016-11-30 Summergrad P. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export Psilocybin for depression and anxiety associated with life-threatening illnesses. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675771 PubMed 27909171 Copy citation Copy BibTeX Unknown journal 2016-11-30 McCorvy JD, Olsen RH, Roth BL. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export The role of psychedelics in palliative care reconsidered: A case for psilocybin. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675781 PubMed 27909173 Copy citation Copy BibTeX Unknown journal 2016-11-30 Kelmendi B, Corlett P, Ranganathan M, D'Souza C, Krystal JH. Europe PMC Published psilocybin End-of-Life Distress Other More
Select for export Psilocybin-assisted psychotherapy for dying cancer patients - aiding the final trip. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675783 PubMed 27909174 Copy citation Copy BibTeX Unknown journal 2016-11-30 Spiegel D. Europe PMC Published psilocybin Cancer Patients Other More
Select for export Psilocybin: promising results in double-blind trials require confirmation by real-world evidence. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675784 PubMed 27909175 Copy citation Copy BibTeX Unknown journal 2016-11-30 Breckenridge A, Grobbee DE. Europe PMC Published psilocybin General Other More
Select for export The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116678781 PubMed 27856683 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-16 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyConsciousness Case Report More
Select for export Psychedelics in the treatment of unipolar mood disorders: a systematic review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116679368 PubMed 27856684 Copy citation Copy BibTeX Unknown journal 2016-11-16 Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH. Europe PMC Published psilocybin DepressionClinical TrialSystematic Review Systematic Review More
Select for export Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinogens and neuroimaging. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neubiorev.2016.10.026 PubMed 27810345 Copy citation Copy BibTeX Unknown journal 2016-10-30 Dos Santos RG, Osório FL, Crippa JAS, Hallak JEC. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyDefault Mode Network Systematic Review More
Select for export Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0022167816673493 Copy citation Copy BibTeX Journal of Humanistic Psychology 2016-10-15 Michael P. Bogenschutz, Alyssa A. Forcehimes OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyClinical Trial Clinical Trial More
Select for export Alterations of consciousness and mystical-type experiences after acute LSD in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-016-4453-0 PubMed 27714429 Copy citation Copy BibTeX Psychopharmacology 2016-10-06 Liechti ME, Dolder PC, Schmid Y. Europe PMC Published psilocybin Brain ImagingConsciousnessAging Observational Study More
Select for export Psilocybin: panacea or placebo? No abstract availability was recorded for this entry. Details DOI 10.1016/s2215-0366(16)30103-1 PubMed 27568263 Copy citation Copy BibTeX Unknown journal 2016-08-31 Hendrie C, Pickles A. Europe PMC Published psilocybin Depression Other More
Select for export Question-based Drug Development for psilocybin. No abstract availability was recorded for this entry. Details DOI 10.1016/s2215-0366(16)30214-0 PubMed 27568265 Copy citation Copy BibTeX Unknown journal 2016-08-31 Dijkstra FM, Jacobs GE, Cohen AF. Europe PMC Published psilocybin Depression Other More
Select for export Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116662634 PubMed 27578767 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-08-29 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW Europe PMC Published psilocybin WellbeingEmotional ProcessingObservational Study Observational Study More
Select for export Return of the psychedelics: Psilocybin for treatment resistant depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ajp.2016.08.010 PubMed 27931907 Copy citation Copy BibTeX Unknown journal 2016-08-22 Patra S. Europe PMC Published psilocybin DepressionAddictionBrain Imaging Clinical Trial More
Select for export Psilocybin for treating substance use disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14737175.2016.1220834 PubMed 27684102 Copy citation Copy BibTeX Unknown journal 2016-08-11 de Veen BT, Schellekens AF, Verheij MM, Homberg JR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Clinical Trial More
Select for export Treating Addiction: Perspectives from EEG and Imaging Studies on Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/bs.irn.2016.06.005 PubMed 27503452 Copy citation Copy BibTeX Unknown journal 2016-07-24 Tófoli LF, de Araujo DB. Europe PMC Published psilocybin DepressionAddictionBrain Imaging Review Article More
Select for export Long-term follow-up of psilocybin-facilitated smoking cessation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3109/00952990.2016.1170135 PubMed 27441452 Copy citation Copy BibTeX The American Journal of Drug and Alcohol Abuse 2016-07-20 Johnson MW, Garcia-Romeu A, Griffiths RR. Europe PMC Published psilocybin AddictionReceptor PharmacologySpirituality Other More
Select for export Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyw016 PubMed 26874330 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2016-07-04 Maqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J Europe PMC Published psilocybin AddictionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Hallucinogen Use Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.chc.2016.03.006 PubMed 27338969 Copy citation Copy BibTeX Child and adolescent psychiatric clinics of North America 2016-06-30 Hardaway R, Schweitzer J, Suzuki J PubMed Published psilocybin AdolescentsAdverse Events Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.